bristol myers said has filed investigational new drug application with food and drug administration requesting agency allow testing its aids vaccine humans company said filed application behalf its oncogen subsidiary which developed vaccine did not name drug bristol myers third largest drug company said considerable work remains done before determined whether new drug application will develpoed for submission fda investigational new drug application first step testing agent after clinical studies establish safety and efficacy agent company then submits new drug application fda may three five years before new drug application submitted and another two three years before fda approves drug for marketing earlier this month bristol myers said vaccine produced antibodies aids virus mice and monkeys vaccine uses live smallpox vaccine carry two protein aids virus may theory prod immune system produce neutralizaing antibodies against aids company second organization has sought premission for human testing aids vaccine team headed allan goldstein george washington university washington was first repligen corp has said plans seek regulatory permission test its aids vaccine summer and genentech inc has also said plans ask fda approve human testing its aids vaccine later this year reuter 